Amylin-based obesity therapy: a meta-analysis of Cagrilintide and CagriSema versus placebo.
Summary withdrawn
TitrateLab removes an AI-written study summary when it states findings we cannot trace to the study's own record, or when the study falls outside the compounds we track. Read the original record through the link above.
cagrilintide
semaglutide
cagrisema
obesity
weight-loss
meta-analysis